Death reports linked to Ozempic and similar drugs indicate users suffered from intestinal masses, stomach paralysis, pancreatic cancer and seizures.
Lawsuit indicates that Novo Nordisk fails to adequately disclose serious risks, indicating some doctors estimate 10% of users discontinue due the severity of the Ozempic side effects.
The U.S. District Judge recently appointed to preside over all federal GLP-1 RA lawsuits is expected to appoint a group of Ozempic lawyers to take certain actions during the MDL proceedings that benefit all plaintiffs.
Researchers indicate short-term benefits of the diet do not negate the negative side effects of intermittent fasting, which may increase the risk of heart disease.
Drug maker plans to pursue legal remedies against compounding pharmacies, medical spas and other entities that claim to sell generic versions of Mounjaro and Zepbound.
Lawyers involved in stomach paralysis lawsuits against Ozempic, Wegovy and other GLP-1 medication manufacturers will meet with the judge to discuss the organizational structure of the recently formed MDL.
Researchers noted that side effects of Ozempic and similar drugs were particularly linked to an increased risk in eating disorders, such as self-induced vomiting and fear of eating.
MDL Panel rejected Eli Lilly's request to exclude Mounjaro lawsuits from other GLP-1 stomach paralysis lawsuits against Novo Nordisk, which manufactures Ozempic, Wegovy and Rybelsus.
Yellow oleander poisoning from Tejocote Root may result in nausea, vomiting, heart problems and even death, after using certain versions of the weight loss supplements
The FDA has reportedly seized thousands of fake Ozempic products over the last year, the report indicates.
